Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,096 public trials 1,232 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Active, Not Recruiting

Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma

NCT05315258

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +16 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust (Screening only) Cambridge, United Kingdom
  • The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • The Clatterbridge Cancer Centre Liverpool, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Active, Not Recruiting

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

NCT03739372

Conditions
Astrocytoma, Cancer, Glioblastoma, +12 more
Locations
  • University of California, San Diego Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
View Trial Details
Active, Not Recruiting

Fimepinostat in Treating Brain Tumors in Children and Young Adults

NCT03893487

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +23 more
Locations
  • Children's Hospital Los Angeles (CHLA) Los Angeles, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin

NCT06640530

Conditions
Advanced Melanoma, Melanoma, Melanoma (Skin), +11 more
Locations
  • Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus
  • Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus
  • Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
  • State Institution "Republic Scientific and Practical Centre for Oncology and Medical Radiology Named after N.N.Aleksandrov" Minsk, Belarus
View all 44 locations
View Trial Details
Active, Not Recruiting

A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma

NCT05751928

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +12 more
Locations
  • State Institution "Republican Scientific and Practical Center of Oncology and Medical Radiology named after A.I. N.N. Alexandrov" Lesnoy, Belarus
  • Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
  • State Institution "Mogilev Regional Oncological Dispensary" Mogilev, Belarus
  • Healthcare Institution "Vitebsk Regional Clinical Oncology Center" Vitebsk, Belarus
View all 36 locations
View Trial Details

Related conditions